Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine

NCT05835635 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Pontificia Universidad Catolica de Chile

Collaborators